cancer risk with semaglutide (Ozempic) carries FDA warnings for thyroid C-cell tumors based on rodent studies, emerging human data showing higher thyroid in early users. Over 2,900 lawsuits allege inadequate warnings for Weight-loss drugs may lower cancer

Skinny Shot

Patients must check with a doctor before seeking retatrutide

Our team works with you to develop a plan that includes nutritional guidance, exercise recommendations, and ongoing support to help you achieve your weight loss goals in a safe, sustainable way

Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily used to manage type 2 diabetes and, in some formulations, chronic weight management

Patients lose an average of 510% of body weight on this extended-release combination medication

Often, you will be able to consistently lose weight at a dose much lower than the maximum